SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Dadx4
Search This Board:
Last Post: 10/25/2016 10:08:44 PM - Followers: 322 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 10/25/2016 04:34:47 PM
ONVO News: Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results 10/24/2016 08:05:00 AM
ONVO News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 10/21/2016 04:38:43 PM
ONVO News: Organovo Prices Approximately $25 Million Public Offering of Common Stock 10/20/2016 09:11:55 AM
ONVO News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 10/19/2016 04:21:10 PM
News News Alert: Current Report Filing (8-k) 10/25/2016 04:34:47 PM
#9373  Sticky Note ONVO 8K---EXCHANGE CHANGE; Dadx4 07/26/16 08:13:34 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9647   I'd like to think they're a bit brighter WHP03 10/25/16 10:08:43 PM
#9646   OCT 25 Notice: Alvie 10/25/16 06:26:46 PM
#9645   Stem Cell on the Mesa 2016 - ONVO WHP03 10/25/16 08:42:17 AM
#9644   Nice. Thanks for that. :-) rayank 10/24/16 04:22:17 PM
#9643   Thomson Reuters/Verus upgrades ORGANOVO HOLDINGS INC from HOLD RandolRocketman 10/24/16 11:29:33 AM
#9642   Yahoo Message Board Comment: WHP03 10/22/16 06:14:55 PM
#9641   Market Capitalization $322.45M RandolRocketman 10/20/16 11:50:13 AM
#9640   From Organovo's Oct 11 preliminary report, it would Alvie 10/20/16 11:14:39 AM
#9639   I am not surprised by this at all, RandolRocketman 10/20/16 11:06:03 AM
#9638   Is this the start of the short squeeze? RallyTheMarket 10/20/16 10:43:20 AM
#9637   I do feel like we were a bit BuckeyeStocks 10/20/16 10:13:38 AM
#9636   Thanks for the bold face lies last conference bettyfordallstar 10/20/16 09:21:54 AM
#9635   Offering will come at a deep discount to jones99 10/20/16 04:29:13 AM
#9634   "The offering is subject to market and other rayank 10/19/16 06:01:18 PM
#9633   More dilution.. ugly short term squashjohn 10/19/16 04:46:35 PM
#9632   Remember back in early Sept when I compiled WHP03 10/19/16 01:12:02 AM
#9631   Short squeeze... more than likely... but it may WHP03 10/18/16 04:12:36 PM
#9630   They rang a bell maybe 3 years ago. Windbag1014 10/18/16 04:12:26 PM
#9629   I said "hope that there is a short rayank 10/18/16 04:08:36 PM
#9628   A short squeeze? What's the catalyst? Seems that's RallyTheMarket 10/18/16 03:43:48 PM
#9627   Got your PM. Thanks. I cannot PM. Yeah rayank 10/18/16 03:36:34 PM
#9626   Yeah but it didn't help any for now. Weird! rayank 10/18/16 03:01:03 PM
#9625   Current job ONVO job openings... 10-18-16 WHP03 10/18/16 09:44:58 AM
#9624   Nice to see the ONVO Team ringing the WHP03 10/18/16 09:33:55 AM
#9623   Organovo Holdings Inc (NASDAQ: ONVO) pre-announced a strong rayank 10/17/16 11:05:02 AM
#9622   YES: ONVO to Ring Opening Bell tomorrow rayank 10/17/16 11:03:42 AM
#9621 Dadx4 10/17/16 10:17:30 AM
#9620   ONVO picked as better buy: "One of these rayank 10/14/16 05:46:44 PM
#9619   It's going nowhere. Charts are worthless on ONVO. RallyTheMarket 10/14/16 02:59:36 PM
#9618   Charts.... hanging in there just below the midline WHP03 10/12/16 11:00:22 PM
#9617   Nice! Thanks for that WHP. :-) rayank 10/12/16 07:14:33 AM
#9616   Yr Over Yr, Qtr to Qtr Revenue Comparison: WHP03 10/11/16 09:21:40 PM
#9615   ONVO 8K; Dadx4 10/11/16 08:34:31 AM
#9614   (In Elmer Fudd voice) Well what do flick 10/10/16 03:07:00 PM
#9613   Soilent green, for those of you old enough bettyfordallstar 10/08/16 12:11:12 AM
#9612   Not to say we shouldn't terraform Mars, and RandolRocketman 10/07/16 06:43:43 PM
#9611   Would it be considered within Organovo's IP though? RandolRocketman 10/07/16 06:40:50 PM
#9610   NASA and Musk thinking about just that. dshade 10/07/16 02:38:37 PM
#9608   Oh god. Bring on the McPrinters at Mickey D's. nsomniyak 10/06/16 02:39:56 PM
#9607   Sure no problem, as long as you don't RandolRocketman 10/06/16 01:15:10 PM
#9606   I believe this had been done years ago. Herringaid 10/06/16 11:26:38 AM
#9605   When will the company start printing meat for dds2th 10/06/16 07:10:57 AM
#9604   Organovo Introduces 3D Bioprinted Human Liver as Leading Dadx4 10/05/16 08:54:29 AM
#9603   I thought when I first got into this RandolRocketman 10/01/16 11:18:04 PM
#9602   That is a lot of events! RandolRocketman 10/01/16 10:56:02 PM
#9601   Several upcoming events for ONVO: WHP03 09/30/16 05:37:38 PM
#9600   Well look, this ain't SFOR I know, but RandolRocketman 09/29/16 01:02:09 PM
#9599   It's hard to believe? It's hard to believe RallyTheMarket 09/29/16 12:27:33 PM
#9598   Yep. It's kind of hard to believe this RandolRocketman 09/29/16 11:42:08 AM
#9597   Interesting spot here. nice upgrade. dshade 09/29/16 11:32:47 AM